These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 14947518)

  • 21. High toxicity of pure botulinum type D toxin.
    WENTZEL LM; STERNE M; POLSON A
    Nature; 1950 Oct; 166(4226):739-40. PubMed ID: 14780226
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mechanism of development of paralysis in cats poisoned with botulin toxin A].
    MIKHAILOV VV
    Biull Eksp Biol Med; 1956 Apr; 41(4):31-3. PubMed ID: 13328925
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: Further studies on the characterization of crystalline type A toxin of Clostridium botulinum.
    Schantz EJ; Gasper E
    Jpn J Med Sci Biol; 1975 Feb; 28(1):66-9. PubMed ID: 240052
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation].
    Lysenko AI; Cherniavskiĭ VI; Kulakova GS; Iskritskiĭ GV
    Mikrobiol Zh; 1973; 35(3):308-12. PubMed ID: 4598684
    [No Abstract]   [Full Text] [Related]  

  • 25. [Examination of the possibility of active immunization of experimental animals with oral Clostridium botulinum toxin].
    KATITCH RV
    Rev Immunol Ther Antimicrob; 1952; 16(4-5):309-11. PubMed ID: 13014717
    [No Abstract]   [Full Text] [Related]  

  • 26. [Technique of extraction of the toxin of Cl. botulinum (C) from bacterial bodies].
    KATITCH RV
    Rev Immunol Ther Antimicrob; 1952; 16(6):384-9. PubMed ID: 13048125
    [No Abstract]   [Full Text] [Related]  

  • 27. [Research on botulinum I toxin, anatoxin and antitoxin].
    PREVOT AR; BRYGOO ER
    Ann Inst Pasteur (Paris); 1950 Jul; 79(1):1-13. PubMed ID: 14771601
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure, Function and Evolution of Clostridium botulinum C2 and C3 Toxins: Insight to Poultry and Veterinary Vaccines.
    Chellapandi P; Prisilla A
    Curr Protein Pept Sci; 2017; 18(5):412-424. PubMed ID: 27915984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A
    Nihon Saikingaku Zasshi; 1977 Nov; 32(6):805-11. PubMed ID: 342740
    [No Abstract]   [Full Text] [Related]  

  • 30. Structure of the outer membrane and toxin localization of Clostridium botulinum type E [proceedings].
    Ohyama A; Yabuuchi E; Ito T; Tanimura E; Yamamoto N
    Jpn J Med Sci Biol; 1978 Apr; 31(2):170-2. PubMed ID: 355685
    [No Abstract]   [Full Text] [Related]  

  • 31. First report of an infant botulism case due to Clostridium botulinum type Af.
    de Jong LI; Fernández RA; Pareja V; Giaroli G; Guidarelli SR; Dykes JK; Lúquez C
    J Clin Microbiol; 2015 Feb; 53(2):740-2. PubMed ID: 25502535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods.
    Kautter DA; Solomon HM
    J Assoc Off Anal Chem; 1977 May; 60(3):541-5. PubMed ID: 323214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of six type A strains of Clostridium botulinum that contain type B toxin gene sequences.
    Kirma N; Ferreira JL; Baumstark BR
    FEMS Microbiol Lett; 2004 Feb; 231(2):159-64. PubMed ID: 14987759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [SENSITIVITY OF LABORATORY ANIMALS TO BOTULINUM TOXIN, TYPE C].
    MIERZEJEWSKI J
    Przegl Epidemiol; 1964; 18():77-84. PubMed ID: 14189171
    [No Abstract]   [Full Text] [Related]  

  • 35. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF; Giménez JA
    Rev Argent Microbiol; 1983; 15(1):51-5. PubMed ID: 6400761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugative transfer of the Escherichia coli-Clostridium perfringens shuttle vector pJIR1457 to Clostridium botulinum type A strains.
    Bradshaw M; Goodnough MC; Johnson EA
    Plasmid; 1998 Nov; 40(3):233-7. PubMed ID: 9806860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of pancreatin in examination of mixed cultures for the presence of the toxin of Cl. botulinum].
    SHISHULINA LM
    Gig Sanit; 1962 Jun; 27():53-5. PubMed ID: 13912139
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of salts and colloids on potency of botulinum toxin.
    BOOR AK; TRESSELT HB; SCHANTZ EJ
    Proc Soc Exp Biol Med; 1955 Jun; 89(2):270-2. PubMed ID: 14395288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.